Dalbavancin Hydrochloride 65219-0120
Product NDC
65219-0120- Manufacturer
- Fresenius Kabi Usa, Llc
- Dosage Form
- Injection, Powder, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- November 10, 2025
- Listing Expires
- December 31, 2027
- Application
- ANDA217591
Need to source Dalbavancin Hydrochloride? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Dalbavancin Hydrochloride | 500 mg/25mL |
Drug Class
Lipoglycopeptide Antibacterial [EPC]Lipoglycopeptides [CS]
Packaging Options(1)
1 VIAL in 1 PACKAGE (65219-120-12) / 25 mL in 1 VIAL